Effect of Bromhexine Hydrochloride on patients with COVID-19

Phase 3

Recruiting

• Conditions: Condition 1: Patients with COVID-2019. Condition 2: .; COVID-19, virus identified; U07.1

• Registration Number: IRCT20200317046797N4
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with COVID-19-induced pneumonia confirmed with PCR
Patients or authorized family members volunteered to participate in this study and signed informed consent.
Both genders
18 to 80 years old

Exclusion Criteria

Patients who are participating in other drug clinical trials
Pregnant or lactating women
Patient with active thrombotic event
Patients with severe respiratory failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospitalization days. Timepoint: At baseline and discharge time. Method of measurement: Counting the days.;Need for mechanical ventilation. Timepoint: From baseline to discharge time. Method of measurement: Observation and documents.;Condition of discharge (death or recovery). Timepoint: End of hospitalization. Method of measurement: Observation and documents.;Period of mechanical ventilation. Timepoint: End of hospitalization. Method of measurement: Documents of hospitalization.